A randomized, controlled phase III global trial comparing sipuleucel-T plus androgen deprivation therapy versus androgen deprivation therapy alone in men with metastatic androgen dependent (hormone sensitive) prostate cancer.

Trial Profile

A randomized, controlled phase III global trial comparing sipuleucel-T plus androgen deprivation therapy versus androgen deprivation therapy alone in men with metastatic androgen dependent (hormone sensitive) prostate cancer.

Planning
Phase of Trial: Phase III

Latest Information Update: 07 Jun 2011

At a glance

  • Drugs Antiandrogens; Sipuleucel-T
  • Indications Prostate cancer
  • Focus Registrational; Therapeutic Use
  • Acronyms ACTION
  • Most Recent Events

    • 07 Jun 2011 Trial design presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
    • 19 May 2011 STudy title is not an official title. Additional info taken from ASCO abstract but ADNM not available on CA yet. Will need adding.
    • 19 May 2011 Planned number of patients changed to 1684.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top